Acquisition of Chemical and Pharmaceutical Products for the Center for Clinical and Robotics Simulation

BoliviaTenders notice for Acquisition of Chemical and Pharmaceutical Products for the Center for Clinical and Robotics Simulation. The reference ID of the tender is 118959677 and it is closing on 15 May 2025.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Chemical and Pharmaceutical Products for the Center for Clinical and Robotics Simulation
  • BOT Ref No: 118959677
  • Deadline: 15 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 25-0046-45-1553397-1-1
  • Purchaser's Detail :
  • Purchaser : NATIONAL HEALTH SCHOOL
    Freddy Condo Mamani (telf 2440540)

  • Description :
  • The bidders are invited to the acquisition of chemical and pharmaceutical products for the Center for Clinical and Robotics Simulation
    State: in force
    Entity: National Health School
    Department: La Paz
    Publication date: May 8, 2025
    Modality: CNC
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us